systematic_review
2019
High Quality
Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review of Randomized Controlled Trials
Unknown authors
Published in Acta Dermato-Venereologica
Key Findings
Pooled randomized trial data showed a small but significant increase in sexual adverse events with finasteride; dutasteride data were too limited for firm conclusions.
Conclusions
Systemic DHT reduction carries a measurable sexual side-effect risk that should be disclosed.
Outcomes Measured
Results were significant for finasteride but not significant for dutasteride. As studies into dutasteride were limited, further trials are required.
Study Details
Year:2019
Quality Score:7/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.